Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04624633
Title AU2 In Relapsed and Untreated CLL
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jennifer R. Brown, MD, PhD

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia


Acalabrutinib + Ublituximab + Umbralisib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.